Results of Florida's amyotrophic lateral sclerosis surveillance project, 2009-2011

BMJ Open

Volumn 5, Issue 4, 2015, Pages

  Freer, Cecilia ^a   Hylton, Tara ^b   Jordan, Heather M ^c   Kaye, Wendy E ^c   Singh, Sabrina ^b   Huang, Youjie ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b FLORIDA DEPARTMENT OF HEALTH   (United States)

^c McKing Consulting Corp   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOXIC SUBSTANCE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASIAN; DEMENTIA; DISEASE REGISTRY; DISEASE SURVEILLANCE; ELECTROMYOGRAPHY; FEMALE; FOLLOW UP; HISPANIC; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIDDLE AGED; MINORITY GROUP; MOTOR NEURON DISEASE; NEUROLOGIST; PATIENT INFORMATION; PREVALENCE; QUALITY CONTROL; UNITED STATES; VERY ELDERLY; AGE DISTRIBUTION; FLORIDA; HEALTH SURVEY; SEX RATIO;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; DEMENTIA; FEMALE; FLORIDA; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; SEX DISTRIBUTION;

EID: 84929192592     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-007359     Document Type: Article

References (25)

1. Eisen A. Amyotrophic lateral sclerosis: a review. B C Med J 2002;44:362-6.
2. Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of Amyotrophic Lateral Sclerosis. World Federation of Neurology Research Group on Motor Neuron Diseases. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-9.
3. Byrne S, Walsh C, Lynch C, et al. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurolo Neurosurg Psychiatry 2011;82:623-7.
4. Hirtz D, Thurman D, Gwinn-Hardy K, et al. How common are the "common" neurologic disorders? Neurology 2007;68:326-37.
5. Chio A, Logrosino G, Traynor BJ, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology 2013;41:118-30.
6. Sorenson J, Stalker A, Kurland L, et al. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998. Neurology 2002;59:280-2.
7. Wagner L, Archer NP, Williamson DM, et al. Prevalence of amyotrophic lateral sclerosis in Texas, 1998-2003. Tex Med 2012;108:e1.
8. Antao V, Horton D. The national amyotrophic lateral sclerosis (ALS) registry. J Environ Health 2012;74:28-30.
9. Mehta P, Antao V, Kaye W, et al. Prevalence of amyotrophic lateral sclerosis-United States, 2010-2011. MMWR Morb Morta Wkly Rep 2014;63(Suppl 7):1-13.
10. United States Census Bureau. State and County QuickFacts. United States Census Bureau/American Factfinder Web site 2011. http://quickfacts.census.gov/qfd/states/12000.html (accessed 23 Jun 2014).
11. United States Department of Health and Human Services. International classification of diseases, 9th revision, clinical modifications (ICD-9-CM), 6th edn. DHHS Publication No. (PHS) 96-1260. Washington, DC: Health Care Financing Administration, 1997.
12. World Health Organization. International statistical classification of diseases and related health problems, Tenth revision. Geneva: World Health Organization, 1992.
13. Logroscino G, Traynor B, Hardiman O, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry 2010;81:385-90.
14. Jordan H, Fagliano J, Rechtman L, et al. Population-based surveillance of amyotrophic lateral sclerosis in New Jersey, 2009-2011. Neuroepidemiology 2014;43:49-56.
15. Fong GCY, Cheng TS, Lam K, et al. An epidemiological study of motor neuron disease in Hong Kong. Amyotroph Lateral Scler 2005;6:164-8.
16. Gundogdu B, Al-Lahham T, Kadlubar F, et al. Racial differences in motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener 2014;15:114-18.
17. Zaldivar T, Gutierrez J, Lara G, et al. Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study. Neurology 2009;72:1640-5.
18. Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology 2007;68:1002-7.
19. Logroscino G, Traynor BJ, Hardiman O, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry 2008;79:6-11.
20. Balluz LS, Okoro CA, Strine TW. Access to health care and preventive services among Hispanics and non-Hispanics - United States. MMWR Morb Morta Wkly Rep 2004;53:937-41.
21. Traynor BJ, Codd MB, Corr B, et al. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: a population-based study. Arch Neurol 2000;57:1171-6.
22. O'Toole O, Traynor BJ, Brennan P, et al. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry 2008;79:30-2.
23. Phukan J, Elamin M, Bede P, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 2012;83:102-8.
24. Ringholz G, Appel S, Bradshaw M, et al. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 2005;65:586-90.
25. Stickler DE, Royer JA, Hardin JW. Accuracy and usefulness of ICD-10 death certificate coding for the identification of patients with ALS: results from the South Carolina ALS Surveillance Pilot Projects. Amyotroph Lateral Scler 2012;13:69-73.